OSE Immunotherapeutics Publishes Positive Preclinical COVID-19 Vaccine Results With Multi-Target Vaccine CoVepiT

    NEXT STORY
    Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
    PREV STORY
    FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Innate Pharma in-licenses OREGA biotech’s first-in-class anti-CD39 checkpoint inhibitor program

    This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the ...

    author_avatar
    NASDAQ Market News

    AB Science will host a live webcast on Friday December 11, 2020 on masitinib’s results in pancreatic cancer

    author_avatar
    NASDAQ Market News

    Constellation Pharmaceuticals Appoints Jessica Christo as Chief Product Development Officer

    author_avatar
    NASDAQ Market News